Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $175.00

Дата публикации: 10-08-2026 05:48:48

Becton, Dickinson and Company (NYSE:BDX – Free Report) had its target price hoisted by Piper Sandler from $161.00 to $175.00 in a research report released on Friday,Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock. BDX has been the subject of several other research reports. Evercore set a $180.00 price […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	ICU Medical (NASDAQ:ICUI) Price Target Raised to $195.00	0	11.84	10-08-2026
2	Teleflex’s (TFX) Overweight Rating Reiterated at Piper Sandler	0	10.31	10-08-2026
3	Piper Sandler Cuts ResMed (NYSE:RMD) Price Target to $225.00	0	10.45	10-08-2026
4	Definium Therapeutics’ (DFTX) “Overweight” Rating Reiterated at Piper Sandler	0	8.75	10-08-2026
5	Etsy (NYSE:ETSY) Price Target Raised to $80.00	0	12.29	10-08-2026
6	BP (NYSE:BP) Price Target Raised to $43.00	0	12.22	10-08-2026
7	STERIS’s (STE) “Overweight” Rating Reiterated at Piper Sandler	0	9.98	10-08-2026
8	BTIG Research Cuts NRx Pharmaceuticals (NASDAQ:NRXP) Price Target to $10.00	0	9.08	10-08-2026
9	Celldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $53.00	0	11.84	10-08-2026
10	Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler	0	9.05	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.26. Источник: www.americanbankingnews.com.